NCT06371820View on ClinicalTrials.gov

ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)

Active, not recruitingOBSERVATIONAL
Enrollment

13,000,000

Participants

Timeline

Start Date

January 1, 1965

Primary Completion Date

May 17, 2043

Study Completion Date

May 17, 2043

Conditions
Gastrointestinal Diseases
Interventions
OTHER

ESPRESSO [The study has no intervention]

This study has no interventions.

All Listed Sponsors
lead

Karolinska Institutet

OTHER